Kymera Therapeutics (KYMR) Net Margin Growth (1y) (2020 - 2026)
Kymera Therapeutics (KYMR) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Kymera Therapeutics |
8.84 Bn |
8.19 Bn |
- |
9,528.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
9,528.00 |
| Dec 31, 2025 |
-207,381.00 |
| Sep 30, 2025 |
-130,272.00 |
| Jun 30, 2025 |
-50,362.00 |
| Mar 31, 2025 |
17,528.00 |
| Dec 31, 2024 |
-92,688.00 |
| Sep 30, 2024 |
-55,216.00 |
| Jun 30, 2024 |
7,098.00 |
| Mar 31, 2024 |
-3,965.00 |
| Dec 31, 2023 |
18,602.00 |
| Sep 30, 2023 |
-66,793.00 |
| Jun 30, 2023 |
11,467.00 |
| Mar 31, 2023 |
-4,810.00 |
| Dec 31, 2022 |
685.00 |
| Sep 30, 2022 |
-30,907.00 |
| Jun 30, 2022 |
-21,647.00 |
| Mar 31, 2022 |
-31,435.00 |
| Dec 31, 2021 |
-12,366.00 |
| Sep 30, 2021 |
-8,621.00 |
| Jun 30, 2021 |
29,230.00 |
